In vivo models of human immunity in human tumor-bearing mice are frequently used to study mechanisms of targeted immunotherapies, safety, and efficacy. In a recent webinar Jenny Rowe, PhD, Scientist ...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL), a leading early-stage contract research organization (CRO), announced the North American launch of its ...

Due to advancements in genetic engineering, small animal models are continuing to change in response to market needs. Model developers strive to better reflect the role of this important asset in both ...

WILMINGTON, Del., July 26, 2022 /PRNewswire/ -- In order to bring new cutting-edge research models to the market to accelerate the development of novel therapeutics for a host of unmet medical needs, ...

Charles River Laboratories is incorporating HemaCare’s human peripheral blood mononuclear cells (PBMCs) into its NCG mouse model, further complementing its services in immuno-oncology and infectious ...

Selecting an appropriate mouse model is one of the most important decisions a pre-clinical researcher can make. Which is best suited for immuno-oncology? Cancer research and drug discovery has changed ...

The patient-derived xenograft model market is expected to reach US$1,116.73 million by 2031 from US$468.75 million in 2024; it is expected to register a CAGR of 13.4% during the forecast period.

WILMINGTON, Del., July 26, 2022 /PRNewswire/ -- In order to bring new cutting-edge research models to the market to accelerate the development of novel therapeutics for a host of unmet medical needs, ...